Navidea Biopharmaceuticals (NAVB) Posts Q3 Loss of 9c/Share
Tweet Send to a Friend
Navidea Biopharmaceuticals (NYSE: NAVB) reported Q3 loss of $0.09 per ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
